European Academy of Dermatology and Venereology

A review of treatment for dermatofibrosarcoma
September 17, 2018

Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.

Two opposing views on how best to treat actinic keratosis
September 17, 2018

Is it just a “spot” or precancerous lesion? Two physicians debate how best to treat actinic keratosis in a talk given at EADV last week.

Surgical treatment for basal cell carcinomas still the best bet
September 17, 2018

There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.

Treating moles and melanoma during pregnancy
September 17, 2018

A pregnancy-associated melanoma (PAM) prognosis does not appear to be worse than melanoma in non-pregnant controls, researchers reported at EADV. Nonetheless, measures should be taken to protect the fetus in the treatment and imaging of PAM.

Combination therapies may be best for tattoo removal
September 17, 2018

EADV report summarizes the latest advances in laser technology for tattoo removal.

Life-threatening emergency cases in dermatology
September 15, 2018

Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.

Dupilumab may be for adolescents too, EADV report shows
September 15, 2018

A study presented at EADV in Paris today showed that dupilumab met its primary endpoints in a phase three study of adolescents with moderate-to-severe atopic dermatitis.

JAK trial effectively reverses alopecia areata
September 15, 2018

EADV report shows that two JAK inhibitors reverses alopecia areata in some patients.

EADV report addresses novel treatments for cutaneous lymphoma
September 15, 2018

Potential new treatment with targeted monoclonal antibodies offers new hope for cutaneous lymphoma patients.

EADV report: Arriving at a skin hemorrhaging diagnosis
September 15, 2018

Clinicians are more likely to correctly identify the lesions’ underlying cause with careful observation rather than with several lab tests.